1. Home
  2. MXE vs INTS Comparison

MXE vs INTS Comparison

Compare MXE & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

SELL

Current Price

$13.13

Market Cap

55.7M

Sector

Finance

ML Signal

SELL

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

N/A

Current Price

$3.13

Market Cap

13.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
INTS
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.7M
13.7M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
MXE
INTS
Price
$13.13
$3.13
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $18.67
AVG Volume (30 Days)
2.5K
★ 19.9K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 2.66%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.57
$0.22
52 Week High
$14.30
$8.06

Technical Indicators

Market Signals
Indicator
MXE
INTS
Relative Strength Index (RSI) 56.49 45.93
Support Level $12.83 $3.10
Resistance Level $13.60 $4.17
Average True Range (ATR) 0.30 0.29
MACD 0.06 0.01
Stochastic Oscillator 71.31 58.00

Price Performance

Historical Comparison
MXE
INTS

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek high total return through capital appreciation and current income. It invests in equity securities, convertible securities and debt securities and may also invest in other securities such as capital development certificates, real estate investment trusts, mutual funds, exchange traded funds, preferred stocks, rights and warrants.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: